Evidence map›Paper›PMID 23147737›Full record

ArticleAntimicrobial agents and chemotherapy2013

Emergence and spread of plasmid-borne tet(B)::ISCR2 in minocycline-resistant Acinetobacter baumannii isolates.

Elisabet Vilacoba, Marisa Almuzara, Lucia Gulone, German Matías Traglia, Silvia A Figueroa, Gabriela Sly, Analia Fernández, Daniela Centrón, María Soledad Ramírez

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Review
  3. Minocycline Susceptibility andInfection and drug resistance · 2022
    Article
  4. Annals of laboratory medicine · 2021
    Article
  5. What do we know about plasmids carried by members of the Acinetobacter genus?World journal of microbiology & biotechnology · 2020
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Diversity and Antibiotic Susceptibility ofFrontiers in microbiology · 2018
    Article
  14. Biology ofFrontiers in cellular and infection microbiology · 2017
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Elisabet VilacobaInstituto de Microbiología y Parasitología Médica (IMPaM, UBA-CONICET), Facultad de Medicina, Universidad de Buenos Aires, Argentina.
Marisa Almuzara
Lucia Gulone
German Matías Traglia
Silvia A Figueroa
Gabriela Sly
Analia Fernández
Daniela Centrón
María Soledad Ramírez
University of Buenos Aires · ARConsejo Nacional de Investigaciones Científicas y Técnicas · ARFundacion Favaloro Hospital Universitario · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to minocycline has emerged in multidrug-resistant Acinetobacter baumannii isolates from Buenos Aires hospitals. Few reports about the description and dispersion of tet genes in this species have been published. We observed the presence of tet(B) in all minocycline-resistant isolates. This gene was found to be associated with the ISCR2 mobile element, which may, in part, explain its dispersion.

Indexed as

PlasmidsAcinetobacter baumanniiAcinetobacter InfectionsAnti-Bacterial AgentsArgentinaBase SequenceHumansMicrobial Sensitivity TestsMinocyclineMolecular Sequence DataRetroelementsSequence Analysis, DNATetracycline ResistanceAnti-Bacterial AgentsMinocyclineRetroelements

Identifiers

PMID23147737
PMCPMC3535920
OpenAlexW2124444481

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.